Ra Pharmaceuticals
Cambridge, US · Founded 1928 · Delaware corporation · 15,154 employees on LinkedIn · 3 known investors
Find your way into Ra Pharmaceuticals
46 people in our graph share verified history with the Ra Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.
Adam Bruceunlockedknows Doug Treco · together at Lightstone Ventures
×11knows the team · via Lightstone Ventures
UCB is a global biopharmaceutical company that develops medicines and treatment-support services for people living with neurological and autoimmune conditions, including rare diseases such as epilepsy. It also runs a venture arm and patient-support programs alongside its drug development work.
Founders & leadership
Ra Pharmaceuticals was founded in 1928 by Douglas A. Treco.
DA
KB
Kerry BlackinVice President, Operations2010–2020
Board
EM
Edward MathersBoard director
RS
PB
Peter BisgaardBoard director
JL
Jason LettmanBoard director
MG
Markus GoebelBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$29.2M disclosed across 1 round · 2015
▶$29.2MraisedJul 2015 · 11 investors · PharmaceuticalsRule 506(b)
▶$29.2MraisedJul 2015 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Douglas A. TrecoExecutive Officer, Director
- Edward MathersDirector
- Rajeev ShahDirector
- Peter BisgaardDirector
- Jason LettmanDirector
- Kerry BlackExecutive Officer
- Markus GoebelDirector
- Offering amount
- $58.5M
- Amount sold
- $29.2M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Ra Pharmaceuticals do?
- UCB is a global biopharmaceutical company that develops medicines and treatment-support services for people living with neurological and autoimmune conditions, including rare diseases such as epilepsy. It also runs a venture arm and patient-support programs alongside its drug development work.
- Who founded Ra Pharmaceuticals?
- Ra Pharmaceuticals was founded by Douglas A. Treco in 1928.
- Who are Ra Pharmaceuticals's investors?
- Ra Pharmaceuticals's investors include Lightstone Ventures, New Enterprise Associates (NEA), RA Capital.
- How much funding has Ra Pharmaceuticals raised?
- Ra Pharmaceuticals has disclosed $29.2M raised across 1 round.
- Where is Ra Pharmaceuticals headquartered?
- Ra Pharmaceuticals is headquartered in Cambridge, US.